ENCOMPASS HEALTH CORP's ticker is EHC and the CUSIP is 29261A100. A total of 406 filers reported holding ENCOMPASS HEALTH CORP in Q4 2020. The put-call ratio across all filers is 0.44 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $343,891 | +3.4% | 5,120 | +4.2% | 0.00% | 0.0% |
| Q2 2023 | $332,717 | +32.4% | 4,914 | +5.8% | 0.00% | 0.0% |
| Q1 2023 | $251,358 | -9.5% | 4,646 | +0.1% | 0.00% | 0.0% |
| Q4 2022 | $277,667 | +10.6% | 4,642 | +3.5% | 0.00% | -50.0% |
| Q2 2022 | $251,000 | -32.9% | 4,487 | -14.4% | 0.00% | 0.0% |
| Q1 2022 | $374,000 | +3.0% | 5,244 | -5.5% | 0.00% | 0.0% |
| Q4 2021 | $363,000 | -21.9% | 5,547 | -10.1% | 0.00% | -50.0% |
| Q3 2021 | $465,000 | -12.1% | 6,167 | -8.7% | 0.00% | -20.0% |
| Q2 2021 | $529,000 | +5.6% | 6,757 | +10.9% | 0.01% | 0.0% |
| Q1 2021 | $501,000 | +27.8% | 6,094 | +29.1% | 0.01% | 0.0% |
| Q4 2020 | $392,000 | +14.6% | 4,721 | -9.2% | 0.01% | -16.7% |
| Q3 2020 | $342,000 | -90.8% | 5,198 | -91.2% | 0.01% | -90.2% |
| Q2 2020 | $3,705,000 | +21.0% | 58,804 | +17.1% | 0.06% | -9.0% |
| Q1 2020 | $3,061,000 | +37.4% | 50,203 | +56.5% | 0.07% | +91.4% |
| Q4 2019 | $2,227,000 | – | 32,073 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JANA PARTNERS LLC | 2,001,897 | $150,222,000 | 11.74% |
| JET CAPITAL INVESTORS L P | 855,100 | $64,167,000 | 10.95% |
| Davide Leone & Partners Investment Co Ltd. | 735,308 | $55,178,000 | 4.23% |
| Kent Lake Capital LLC | 110,000 | $8,254,000 | 3.55% |
| REINHART PARTNERS, LLC. | 604,274 | $53,309,000 | 2.71% |
| AREX Capital Management, LP | 74,000 | $5,553,000 | 2.59% |
| RK Capital | 179,800 | $13,492,000 | 2.55% |
| Orchard Capital Management, LLC | 108,266 | $8,124,000 | 2.44% |
| BARINGTON CAPITAL GROUP, L.P. | 24,200 | $1,816,000 | 1.88% |
| Sivik Global Healthcare LLC | 100,000 | $7,504,000 | 1.79% |